A Delaware federal jury has rejected a fraudulent inducement claim brought by a physician against NuVasive Inc. The doctor alleged that NuVasive, a medical device manufacturer, had fraudulently influenced him into entering a 2014 agreement concerning patents for spinal implant system components. The jury, however, decided against the physician’s claim, while also dismissing NuVasive’s counterclaim that the doctor breached the agreement by initiating legal proceedings.
The dispute revolved around the terms of the 2014 agreement and the ownership and use of patented technology for spinal implants. This case underscores the complex nature of patent agreements in the medical device industry and the legal challenges that can arise from such high-stakes deals. For further details on the case, visit Law360.